XBiotech Company Description

XBiotech Inc., a biopharmaceutical company, discovers, develops, and commercializes true human monoclonal antibodies for treating various diseases.

It develops a pipeline of product candidates targeting inflammatory and infectious diseases. The company is also developing interleukin-1 alpha therapies to various medical conditions, such as cancer, stroke, heart attack, or arthritis; and mediates tissue breakdown, angiogenesis, the formation of blood clots, malaise, muscle wasting, and general inflammation.

The company was incorporated in 2005 and is headquartered in Austin, Texas.

XBiotech Inc.

Country	Canada
Founded	2005
Industry	Biological Products, Except Diagnostic Substances
Employees	92
CEO	John Simard

Contact Details

Address: 5217 Winnebago Lane Austin, British Columbia 78744 United States
Phone	512 386 2900
Website	xbiotech.com

Stock Details

Ticker Symbol	4XB
Exchange	Frankfurt Stock Exchange
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
SIC Code	2836

Key Executives

Name	Position
John Simard	Chief Executive Officer
Angela Hu	Chief Financial Officer